Polar Capital’s Meridian Bioscience Inc VIVO Stock Holding History

Polar Capital’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,798	Closed	-$275K	–	326
2020 Q2	$275K	Buy	+11,798	New	+$171K	﹤0.01%	268
2017 Q3	–	Sell	-44,600	Closed	-$700K	–	258
2017 Q2	$700K	Hold	44,600	–	–	0.01%	235
2017 Q1	$613K	Hold	44,600	–	–	0.01%	247
2016 Q4	$789K	Hold	44,600	–	–	0.01%	247
2016 Q3	$860K	Buy	44,600 +1,800	+4%	+$35.2K	0.01%	240
2016 Q2	$834K	Hold	42,800	–	–	0.02%	246
2016 Q1	$882K	Hold	42,800	–	–	0.02%	238
2015 Q4	$878K	Hold	42,800	–	–	0.02%	241
2015 Q3	$732K	Hold	42,800	–	–	0.01%	249
2015 Q2	$798K	Hold	42,800	–	–	0.02%	259
2015 Q1	$816K	Hold	42,800	–	–	0.02%	254
2014 Q4	$704K	Hold	42,800	–	–	0.01%	249
2014 Q3	$757K	Hold	42,800	–	–	0.02%	241
2014 Q2	$883K	Hold	42,800	–	–	0.02%	242
2014 Q1	$932K	Buy	42,800 +2,800	+7%	+$64.2K	0.02%	239
2013 Q4	$1.06M	Hold	40,000	–	–	0.03%	243
2013 Q3	$945	Hold	40,000	–	–	0.03%	238
2013 Q2	$857K	Buy	+40,000	New	+$863K	0.03%	227

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Polar Capital's VIVO Position: Q3 2020 in Review

Polar Capital sold out of Meridian Bioscience Inc (VIVO) in Q3 2020, closing a stake of 11,798 shares — an estimated $275K sold.

Polar Capital first reported a position in VIVO in Q2 2013 and held it in 18 quarters. The position peaked at $1.06M in Q4 2013. 191 funds tracked by Wall St. Rank hold VIVO as of Q3 2020.

Polar Capital reported no remaining Meridian Bioscience Inc position as of Q3 2020 after selling out during the quarter.
Polar Capital sold 11,798 Meridian Bioscience Inc shares in Q3 2020, an estimated $275K.
Polar Capital first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 18 quarters.
Polar Capital's Meridian Bioscience Inc position peaked at $1.06M in Q4 2013.
191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.